AU6391199A - Composition and method for treating allergic diseases - Google Patents

Composition and method for treating allergic diseases

Info

Publication number
AU6391199A
AU6391199A AU63911/99A AU6391199A AU6391199A AU 6391199 A AU6391199 A AU 6391199A AU 63911/99 A AU63911/99 A AU 63911/99A AU 6391199 A AU6391199 A AU 6391199A AU 6391199 A AU6391199 A AU 6391199A
Authority
AU
Australia
Prior art keywords
composition
allergic diseases
treating allergic
treating
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63911/99A
Other languages
English (en)
Inventor
Neng-Yang Shih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU6391199A publication Critical patent/AU6391199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU63911/99A 1998-10-09 1999-10-06 Composition and method for treating allergic diseases Abandoned AU6391199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16960998A 1998-10-09 1998-10-09
US09169609 1998-10-09
PCT/US1999/021438 WO2000021564A1 (fr) 1998-10-09 1999-10-06 Composition et procede pour le traitement d'allergies

Publications (1)

Publication Number Publication Date
AU6391199A true AU6391199A (en) 2000-05-01

Family

ID=22616408

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63911/99A Abandoned AU6391199A (en) 1998-10-09 1999-10-06 Composition and method for treating allergic diseases

Country Status (9)

Country Link
EP (1) EP1119372A1 (fr)
JP (1) JP2002527406A (fr)
CN (1) CN1329505A (fr)
AR (1) AR020741A1 (fr)
AU (1) AU6391199A (fr)
CA (1) CA2346228A1 (fr)
CO (1) CO5140080A1 (fr)
PE (1) PE20001095A1 (fr)
WO (1) WO2000021564A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004229507B2 (en) * 2003-04-15 2008-12-18 Merck Frosst Canada & Co. Polymorphic form of montelukast sodium
ATE481968T1 (de) * 2004-07-14 2010-10-15 Inflammation Res Ct Company Lt Verfahren zur hemmung von tumormetastasierung
EP2117538A1 (fr) 2007-01-24 2009-11-18 Glaxo Group Limited Compositions pharmaceutiques contenant du 2-méthoxy-5- (5-trifluorométhyl-tétrazol-i-yl-benzyl) - (2s-phényl-pipéridin-3s-yl-)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9415997D0 (en) * 1994-08-08 1994-09-28 Merck Sharp & Dohme Therapeutic agents
ATE532530T1 (de) * 1994-12-12 2011-11-15 Omeros Corp Bespüllungslösung und deren verwendung zur perioperativen hemmung von schmerzen, entzündungen und/oder spasmen an einer gefässstruktur
GB9521781D0 (en) * 1995-10-24 1996-01-03 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
PE20001095A1 (es) 2000-10-31
JP2002527406A (ja) 2002-08-27
AR020741A1 (es) 2002-05-29
WO2000021564A1 (fr) 2000-04-20
CN1329505A (zh) 2002-01-02
CO5140080A1 (es) 2002-03-22
EP1119372A1 (fr) 2001-08-01
CA2346228A1 (fr) 2000-04-20

Similar Documents

Publication Publication Date Title
AU2593900A (en) Composition and method for treating glaucoma
AU6872498A (en) Method and composition for skin treatment
AU1296099A (en) Methods and compositions for treating dermatoses
AU3512295A (en) Composition and method for treating hair
AU2002219945A1 (en) Composition and method for treating snoring
AU5439996A (en) Compositions and methods for treating pain
AU8693098A (en) Compositions and methods for treating diabetes
AU2327599A (en) Compositions and methods for treating autoimmune diseases
AU4868599A (en) Composition for and method of treating neurological disorders
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AU5336499A (en) Composition and method of treating disease with extract of (musaceas)
EP1143952A3 (fr) Methode et composition de traitement et de prevention de la tuberculose
AU3401199A (en) Method and composition for treating psoriasis
AU3768795A (en) Method and compositions for hair treatment
AU3204899A (en) Hair treatment composition and method
AU6252699A (en) Composition and method for treating allergic diseases
AU3127795A (en) Composition and treatment for baldness
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU6391199A (en) Composition and method for treating allergic diseases
AU2420101A (en) Method and composition for the treatment of pain
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases
AU2393500A (en) Method for preventing and treating the degeneration of neurons
AU7604100A (en) Composition and method for treating burns
AU2461999A (en) Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase